Sign Up for Free!

Continue Analyzing the page and more.

Continue with Google

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

Upgrade to Pro
Home Daily Intelligence Tracker
    • Plans Blog Contact
    NUTRANOMICS, INC. logo

    NUTRANOMICS, INC.

    N/A

    US$12600.0

    N/A

    N/A

    Transparent research score

    MaveScore

    A research prioritization score from 0 to 100. It is model output for watchlist review, not personalized financial advice.

    22 Low confidence Medium
    Fundamentals Oct 31, 2015
    Price Updating
    Confidence Medium

    Stored data quality

    Freshness and coverage checks

    Stored company inputs are available, but some dates or model fields are older or incomplete.

    13/16 Partial or delayed snapshot
    Fundamental period Oct 31, 2015 3875 days old
    Price snapshot Updating Refreshing
    Input coverage 13/16 Stored fields powering this model output
    Confidence impact 3 gaps Missing fields reduce confidence and can limit signal detail

    Quality

    Quality score blends the latest weighted model rank with underlying profitability and dilution ranks.

    11/35 Weak

    Financial Strength

    Financial strength rewards durable profitability, margins, and positive free cash flow.

    10/25 Weak

    Valuation Support

    Valuation favors positive earnings, positive cash flow, and lower price-to-book multiples.

    0/15 Weak

    Momentum

    Momentum needs recent 3-month or 6-month price-change data.

    0/15 Needs Data

    Shareholder Alignment

    Shareholder alignment rewards less dilutive share behavior and enough size for liquid research coverage.

    1/10 Weak

    Positive model output

    More live company inputs are needed before positive research signals can be surfaced.

    Research risks to review

    • Quality score blends the latest weighted model rank with underlying profitability and dilution ranks.
    • Financial strength rewards durable profitability, margins, and positive free cash flow.
    • Valuation favors positive earnings, positive cash flow, and lower price-to-book multiples.

    MaveScore uses historical model inputs, stored company fundamentals, and stored price context for research support only. Review missing inputs and business-specific risks before acting. Missing inputs right now include latest price, 3-month price change, 6-month price change.

    Overview Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Ratio
    Dashboard Funda..tals Deep..lue Prediction Screener Map

    NUTRANOMICS, INC. Overview

    Industry: Drug Manufacturers Specialty & Generic

    Sector: Healthcare

    Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. It offers approximately 480 nutritional supplements, including formulating vitamin, mineral, herbal, and probiotic supplements. The company provides Nutritional Blood Analysis, a tool to examine the customer's blood cells on a video monitor, live, in real time; and the patented Assimilation Enhancing System that improves the absorption of nutrients. In addition, it offers educational services, including various types of analyses, trainings, certifications, and group presentations to individuals and industry professionals. The company distributes its products through sales representatives throughout North America and Asia, as well as through retail stores. Nutranomics, Inc. has a strategic partnership with Terra-Formance, LLC. The company was founded in 1995 and is headquartered in Salt Lake City, Utah.

    NUTRANOMICS, INC. is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

    Score

    Price History & Performance

    Review NUTRANOMICS, INC. in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

    Recent News



    NUTRANOMICS, INC. Competitors

    NUTRANOMICS, INC. operates in the Drug Manufacturers Specialty & Generic industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

    Earnings Per Share

    EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

    Continue the analysis

    Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

    View plans
    Ticker Image

    NUTRANOMICS, INC.

    N/A

    US$12600.0

    N/A

    N/A